Multilocus Sequence Types Associated with Neonatal Group B Streptococcal Sepsis and Meningitis in Canada

ABSTRACT Group B streptococci (GBS), a leading cause of neonatal sepsis and meningitis, are transferred to neonates from colonized mothers during childbirth. Prior studies using multilocus sequence typing (MLST) have found specific GBS clones (e.g., sequence type 17 [ST-17]) to be associated with neonatal disease in several geographic locations. Few population-based studies, however, have been conducted to determine the frequency of disease caused by specific GBS clones. MLST was used to assess the genetic diversity of 192 GBS strains from neonates and young children identified by population-based surveillance in Alberta, Canada, from 1993 to 2002. Comparisons were made to 232 GBS strains collected from colonized pregnant women, and all strains were characterized for one of nine capsule (cps) genotypes. A total of 47 STs were identified, and more than 80% of GBS strains were represented by 7 STs that have been shown to predominate in other populations. ST-17 and ST-19 were more prevalent in strains causing early onset disease (EOD) and late onset disease (LOD) than from pregnant women, whereas STs 1, 12, and 23 were more common in pregnant women. In addition, ST-17 strains and close relatives more frequently caused meningitis than sepsis and LOD versus EOD in this population of neonates. Further research is required to better understand why strains belonging to the ST-17 phylogenetic lineage are more likely to cause both LOD and meningitis and may provide clues into the pathogenesis of these conditions.

[1]  W. Benitz Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005 , 2009 .

[2]  H. Davies,et al.  Genotypic diversity and serotype distribution of group B streptococcus isolated from women before and after delivery. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Dunn,et al.  Population Structure of Invasive and Colonizing Strains of Streptococcus agalactiae from Neonates of Six U.S. Academic Centers from 1995 to 1999 , 2008, Journal of Clinical Microbiology.

[4]  N. Khardori Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005 , 2008 .

[5]  M. Ramirez,et al.  Analysis of Group B Streptococcal Isolates from Infants and Pregnant Women in Portugal Revealing Two Lineages with Enhanced Invasiveness , 2007, Journal of Clinical Microbiology.

[6]  M. Nei,et al.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.

[7]  P. Lanotte,et al.  Evaluation of the Ability of Streptococcus agalactiae Strains Isolated from Genital and Neonatal Specimens To Bind to Human Fibrinogen and Correlation with Characteristics of the fbsA and fbsB Genes , 2006, Infection and Immunity.

[8]  P. Glaser,et al.  Rapid detection of the "highly virulent" group B Streptococcus ST-17 clone. , 2006, Microbes and infection.

[9]  J. Troendle,et al.  Phylogenetic Lineages of Invasive and Colonizing Strains of Serotype III Group B Streptococci from Neonates: a Multicenter Prospective Study , 2006, Journal of Clinical Microbiology.

[10]  B. Spratt,et al.  Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D. Bryant,et al.  A Simple and Robust Statistical Test for Detecting the Presence of Recombination , 2006, Genetics.

[12]  C. Buchrieser,et al.  Genomic diversity and evolution within the species Streptococcus agalactiae. , 2006, Microbes and infection.

[13]  L. Brady,et al.  A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. , 2006, Microbiology.

[14]  D. Huson,et al.  Application of phylogenetic networks in evolutionary studies. , 2006, Molecular biology and evolution.

[15]  H. Davies,et al.  DNA Polymorphism and Molecular Subtyping of the Capsular Gene Cluster of Group B Streptococcus , 2005, Journal of Clinical Microbiology.

[16]  B. Spratt,et al.  Multilocus Sequence Typing of Swedish Invasive Group B Streptococcus Isolates Indicates a Neonatally Associated Genetic Lineage and Capsule Switching , 2005, Journal of Clinical Microbiology.

[17]  T. Peto,et al.  Population structure of group B streptococcus from a low-incidence region for invasive neonatal disease. , 2005, Microbiology.

[18]  M. Wiedmann,et al.  Molecular Subtyping and Characterization of Bovine and Human Streptococcus agalactiae Isolates , 2005, Journal of Clinical Microbiology.

[19]  P. Larsson,et al.  Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  Martin C. J. Maiden,et al.  mlstdbNet – distributed multi-locus sequence typing (MLST) databases , 2004, BMC Bioinformatics.

[21]  T. Peto,et al.  Hyperinvasive Neonatal Group B Streptococcus Has Arisen from a Bovine Ancestor , 2004, Journal of Clinical Microbiology.

[22]  H. Davies,et al.  Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. , 2004, The Journal of infectious diseases.

[23]  N. Uldbjerg,et al.  Dynamics of Streptococcus agalactiae Colonization in Women during and after Pregnancy and in Their Infants , 2004, Journal of Clinical Microbiology.

[24]  Philippe Glaser,et al.  Multilocus Sequence Typing System for Group B Streptococcus , 2003, Journal of Clinical Microbiology.

[25]  H. Davies,et al.  Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. , 2001, The Pediatric infectious disease journal.

[26]  C. Adair,et al.  Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. , 2001, The Journal of infectious diseases.

[27]  R. Platt,et al.  Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[29]  A. Schuchat,et al.  Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. , 1998, The Journal of infectious diseases.

[30]  L. Harrison,et al.  Emergence of serotype V group B streptococcal infection among infants and adults. , 1995, Journal of Infectious Diseases.

[31]  J. Musser,et al.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[33]  D. Martin,et al.  Human and bovine group B streptococci: two distinct populations. , 1984, The Journal of applied bacteriology.

[34]  Jane M. Deeley,et al.  The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci , 1983, British journal of obstetrics and gynaecology.